Healthcare: price vs profit growth, company by company
Data as of 19 Oct 2026 close · BSE
Lowest price for growth: Chandra Bhagat Pharma Limited (P/E 10×, profits +254%) & Fischer Medical Ventures Limited (P/E 12×, profits +179%). Profits fell at 19 companies.
The sector's middle company: P/E 32.0× (was 36.3× a year ago), profits +16.9% over 12 months · High price for its growth
297 companies in this sector Showing the first 3
P/E is on the last 12 months of profit (without one-off items when they are more than a quarter of pre-tax profit) & shows only for profitable companies. Banks, NBFCs & other lenders are valued on their books, so they sit in a group of their own, placed on P/B (latest BSE close ÷ book value per share on the latest balance sheet), with no read; insurers keep P/E. Profit growth is the last 12 months of earnings per share against the 12 months before (restated for splits & bonuses, without large one-offs), the same figure behind the sector's middle company on the Desk; one quarter's jump from a low base no longer moves it. Read: P/E divided by profit growth in %, with growth counted up to 100% (a P/E of 20 with profits up 40% gives 0.5). Up to 0.75 = low price for its growth, 1.5 or more = high, in between = in line. The thin mark on each P/E bar is the sector's middle P/E; very high figures fill the bar. Industries that usually stay cheap (paper, sugar, fertilisers, state-run oil, gas & coal, fuel refining & marketing, jute, print media) sit in their own group, outside the ranking. A map to study, not a list of what to buy.